Apotex Corp. has recalled 3,744 bottles of Aripiprazole (generic Abilify) 15 mg tablets because the medication failed to meet dissolution specifications during testing. This defect means the tablets may not dissolve properly in the body, which can prevent the medication from being absorbed at the intended rate. These prescription tablets were distributed nationwide in 30-count and 1,000-count bottles with expiration dates in February 2021.
If the medication does not dissolve as specified, the patient may not receive the full intended dose of the drug, potentially leading to a loss of symptom control for the conditions being treated.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.